相似文献
1
Computerized neurocognitive testing and its potential for modern psychiatry.
Psychiatry (Edgmont). 2004 Sep;1(2):29-36.
2
Baseline neurocognitive scores in athletes with attention deficit-spectrum disorders and/or learning disability.
J Neurosurg Pediatr. 2013 Aug;12(2):103-9. doi: 10.3171/2013.5.PEDS12524. Epub 2013 Jun 21.
3
Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
Psychiatriki. 2014 Jan-Mar;25(1):27-38.
4
[Supervised off-label prescribing of methylphenidate in adult ADHD].
Encephale. 2019 Feb;45(1):74-81. doi: 10.1016/j.encep.2018.05.008. Epub 2018 Aug 16.
5
Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
Psychiatry Clin Neurosci. 2017 Aug;71(8):554-561. doi: 10.1111/pcn.12523. Epub 2017 May 21.
6
Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence.
Drug Alcohol Depend. 2016 Mar 1;160:97-104. doi: 10.1016/j.drugalcdep.2015.12.040. Epub 2016 Feb 2.
7
A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
J Child Neurol. 2007 Mar;22(3):264-76. doi: 10.1177/0883073807299859.
8
Clinical and cognitive correlates of childhood attention-deficit/hyperactivity disorder in first-episode psychosis: A controlled study.
Eur Neuropsychopharmacol. 2020 Jul;36:90-99. doi: 10.1016/j.euroneuro.2020.05.010. Epub 2020 Jun 12.
9
Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability.
Expert Rev Neurother. 2009 Apr;9(4):489-503. doi: 10.1586/ern.09.2.
10
The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.
Neurosci Biobehav Rev. 2000 Jan;24(1):7-12. doi: 10.1016/s0149-7634(99)00060-3.
引用本文的文献
1
Neurocognitive functioning during adolescence: Spanish validation of the Penn Computerized Neurocognitive Battery.
Int J Methods Psychiatr Res. 2024 Dec;33(4):e2035. doi: 10.1002/mpr.2035.
2
A meta-analysis on the therapeutic efficacy of repetitive transcranial magnetic stimulation for cognitive functions in attention-deficit/hyperactivity disorders.
BMC Psychiatry. 2023 Oct 17;23(1):756. doi: 10.1186/s12888-023-05261-2.
3
Prediction of Poststroke Depression Based on the Outcomes of Machine Learning Algorithms.
J Clin Med. 2022 Apr 18;11(8):2264. doi: 10.3390/jcm11082264.
4
Computerized Neurocognitive Test (CNT) in mild cognitive impairment and Alzheimer's disease.
Dement Neuropsychol. 2014 Apr-Jun;8(2):112-116. doi: 10.1590/S1980-57642014DN82000005.
5
Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care.
Neuropsychiatr Dis Treat. 2015 Jun 12;11:1455-66. doi: 10.2147/NDT.S82881. eCollection 2015.
6
Computerized cognitive testing for older adults: a review.
Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):13-28. doi: 10.1177/1533317514522852. Epub 2014 Feb 13.
7
Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants.
Pharmacognosy Res. 2014 Jan;6(1):12-8. doi: 10.4103/0974-8490.122912.
8
Evaluation of a new computerized psychometric test battery: Effects of zolpidem and caffeine.
J Pharmacol Pharmacother. 2013 Oct;4(4):247-55. doi: 10.4103/0976-500X.119710.
本文引用的文献
1
Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment.
Drug Alcohol Depend. 2003 Aug 20;71(2):207-11. doi: 10.1016/s0376-8716(03)00092-9.
2
Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice.
Psychol Med. 2003 Feb;33(2):217-27. doi: 10.1017/s0033291702007225.
3
Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence.
Drug Alcohol Depend. 2002 Apr 1;66(2):161-71. doi: 10.1016/s0376-8716(01)00197-1.
4
Note on comparability of MicroCog test forms.
Percept Mot Skills. 2001 Dec;93(3):825-8. doi: 10.2466/pms.2001.93.3.825.
5
Assessing cognitive function in clinical trials: latest developments and future directions.
Drug Discov Today. 2002 Jan 1;7(1):29-35. doi: 10.1016/s1359-6446(01)02068-2.
6
Computerized neurocognitive scanning: II. The profile of schizophrenia.
Neuropsychopharmacology. 2001 Nov;25(5):777-88. doi: 10.1016/S0893-133X(01)00279-2.
7
Computerized neurocognitive scanning: I. Methodology and validation in healthy people.
Neuropsychopharmacology. 2001 Nov;25(5):766-76. doi: 10.1016/S0893-133X(01)00278-0.
8
MicroCog: assessment of cognitive functioning.
Neuropsychol Rev. 2001 Jun;11(2):89-100. doi: 10.1023/a:1016671201211.
9
Cerebral injury during cardiopulmonary bypass: emboli impair memory.
J Thorac Cardiovasc Surg. 2001 Jun;121(6):1150-60. doi: 10.1067/mtc.2001.114099.
10
Dose-dependent effects of flumazenil on cognition, mood, and cardio-respiratory physiology in healthy volunteers.
Br Dent J. 2000 Dec 23;189(12):668-74. doi: 10.1038/sj.bdj.4800860.
Zotero 插件